| 3 | 1/1 | 返回列表 |
| 查看: 646 | 回復(fù): 2 | |||
letterman新蟲 (小有名氣)
|
[交流]
Postdoc position in Med Chem, McGill University, Canada
|
|
Position: Postdoctoral fellow in Medicinal Chemistry, under the supervision of Dr. Jian Hui Wu, Lady Davis Institute, McGill University, Montreal, Canada. Project description: Our laboratory is interested in identification and optimization of novel inhibitors against cancer targets. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds. We routinely utilize structure-based approaches to identify top-ranking analogues to be synthesized. Our laboratory includes three components: structure-based drug design, Medicinal chemistry and biological evaluations. The funded projects are as follows: 1) Postdoc position 1: The start time is OCT, 2020. This funded project is to develop novel inhibitors of RanGTPase for ovarian cancer. Our preliminary work has discovered initial hits as novel inhibitors of RanGTPase, which are selectively active against the ovarian cancer cells, with no obvious effects on normal cells. 2) Postdoc position 2: The start time is NOV, 2020. This funded project is to develop novel modulators of Keap1/Nrf2 protein-protein interaction for lung cancer. Keap1 is an endogenous inhibitor of Nrf2. In normal cells, complexation of Keap1 with Nrf2 lead to Nrf2 degradation, resulting in basal level of Nrf2. However, mutation in Keap1 leads to Keap1 mutant that is unable to form a complex with Nrf2, resulting in high level of Nrf2 in cancer cells, which confer drug resistance in cancer patients. Our project is to discover compounds that could repair the interaction of Keap1 mutant with Nrf2, with a view to selectively suppressing Nrf2 level in cancer cells, which subsequently sensitize cancer cells to cancer treatment. We have already discovered initial hits that are selectively active against the Keap1 mutants, which are found in cancer cells, but have no effect on the wild-type Keap1, that are found in normal cells. Qualifications: We are looking for someone who is interested in anticancer drug discovery. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2018 or later. Language required: English Contact: Interested individuals should send a cover letter, CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address: Jian.H.Wu@McGill.CA). |
銀蟲 (著名寫手)

新蟲 (小有名氣)
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 歡迎211本科同學(xué),過(guò)A區(qū)國(guó)家線,A區(qū)非偏遠(yuǎn)一本,交叉學(xué)科課題組 +18 | lisimayy 2026-03-04 | 30/1500 |
|
|---|---|---|---|---|
|
[考研] 化學(xué)專業(yè)調(diào)劑 +5 | 好好好1233 2026-03-04 | 6/300 |
|
|
[考研] 不限學(xué)校專業(yè)的調(diào)劑同學(xué)看過(guò)來(lái) +5 | 啊擺啊擺 2026-03-05 | 9/450 |
|
|
[考研] 286求調(diào)劑 +7 | Faune 2026-03-06 | 7/350 |
|
|
[考研] 材料調(diào)劑 +7 | ounce. 2026-03-04 | 8/400 |
|
|
[考研] 080500材料科學(xué)與工程 +13 | 202114020319 2026-03-03 | 13/650 |
|
|
[基金申請(qǐng)]
|
Doma 2026-03-01 | 10/500 |
|
|
[考研] 304求調(diào)劑 +7 | 曼殊2266 2026-02-28 | 8/400 |
|
|
[論文投稿]
100+4
|
Stray2021 2026-03-03 | 4/200 |
|
|
[基金申請(qǐng)] 沒有青基直接申請(qǐng)面上,感覺自己瘋了 +6 | kevin63t 2026-03-02 | 12/600 |
|
|
[考研] 0703化學(xué) 一志愿東北大學(xué) 279分求調(diào)劑 +4 | 聶樂平 2026-03-03 | 4/200 |
|
|
[考研] 085601 材料305分求助 +4 | 泡泡郵件 2026-03-03 | 6/300 |
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | G212 2026-03-03 | 5/250 |
|
|
[考研] 291求調(diào)劑 +3 | 咕嚕咕嚕123123 2026-03-02 | 4/200 |
|
|
[考研] 291求調(diào)劑 +4 | Afy123456 2026-03-03 | 7/350 |
|
|
[考研] 環(huán)境調(diào)劑 +8 | chenhanheng 2026-03-02 | 8/400 |
|
|
[考研] 307求調(diào)劑 +6 | wyyyqx 2026-03-01 | 6/300 |
|
|
[考研] 306分材料調(diào)劑 +5 | chuanzhu川燭 2026-03-01 | 6/300 |
|
|
[考研] 265分求調(diào)劑不調(diào)專業(yè)和學(xué)校有行學(xué)上就 +6 | 禮堂丁真258 2026-02-28 | 9/450 |
|
|
[考研] 調(diào)劑 +3 | 13853210211 2026-03-02 | 4/200 |
|